Literature DB >> 23108137

A tumorigenic MLL-homeobox network in human glioblastoma stem cells.

Marco Gallo1, Jenny Ho, Fiona J Coutinho, Robert Vanner, Lilian Lee, Renee Head, Erick K M Ling, Ian D Clarke, Peter B Dirks.   

Abstract

Glioblastoma growth is driven by cancer cells that have stem cell properties, but molecular determinants of their tumorigenic behavior are poorly defined. In cancer, altered activity of the epigenetic modifiers Polycomb and Trithorax complexes may contribute to the neoplastic phenotype. Here, we provide the first mechanistic insights into the role of the Trithorax protein mixed lineage leukemia (MLL) in maintaining cancer stem cell characteristics in human glioblastoma. We found that MLL directly activates the Homeobox gene HOXA10. In turn, HOXA10 activates a downstream Homeobox network and other genes previously characterized for their role in tumorigenesis. The MLL-Homeobox axis we identified significantly contributes to the tumorigenic potential of glioblastoma stem cells. Our studies suggest a role for MLL in contributing to the epigenetic heterogeneity between tumor-initiating and non-tumor-initiating cells in glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108137     DOI: 10.1158/0008-5472.CAN-12-1881

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.

Authors:  Alvaro G Alvarado; Praveena S Thiagarajan; Erin E Mulkearns-Hubert; Daniel J Silver; James S Hale; Tyler J Alban; Soumya M Turaga; Awad Jarrar; Ofer Reizes; Michelle S Longworth; Michael A Vogelbaum; Justin D Lathia
Journal:  Cell Stem Cell       Date:  2017-01-12       Impact factor: 24.633

Review 2.  Challenges and opportunities in targeting the menin-MLL interaction.

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

Review 3.  Brain tumor stem cells: Molecular characteristics and their impact on therapy.

Authors:  David L Schonberg; Daniel Lubelski; Tyler E Miller; Jeremy N Rich
Journal:  Mol Aspects Med       Date:  2013-07-04

Review 4.  The evolving landscape of glioblastoma stem cells.

Authors:  Kenneth Yan; Kailin Yang; Jeremy N Rich
Journal:  Curr Opin Neurol       Date:  2013-12       Impact factor: 5.710

Review 5.  Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications.

Authors:  Tamara J Abou-Antoun; James S Hale; Justin D Lathia; Stephen M Dombrowski
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 6.  Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.

Authors:  Eleonore Maury; Rintaro Hashizume
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

7.  Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules.

Authors:  Rutger K Balvers; Anne Kleijn; Jenneke J Kloezeman; Pim J French; Andreas Kremer; Martin J van den Bent; Clemens M F Dirven; Sieger Leenstra; Martine L M Lamfers
Journal:  Neuro Oncol       Date:  2013-09-17       Impact factor: 12.300

8.  Epigenomic alterations define lethal CIMP-positive ependymomas of infancy.

Authors:  S C Mack; H Witt; R M Piro; L Gu; S Zuyderduyn; A M Stütz; X Wang; M Gallo; L Garzia; K Zayne; X Zhang; V Ramaswamy; N Jäger; D T W Jones; M Sill; T J Pugh; M Ryzhova; K M Wani; D J H Shih; R Head; M Remke; S D Bailey; T Zichner; C C Faria; M Barszczyk; S Stark; H Seker-Cin; S Hutter; P Johann; S Bender; V Hovestadt; T Tzaridis; A M Dubuc; P A Northcott; J Peacock; K C Bertrand; S Agnihotri; F M G Cavalli; I Clarke; K Nethery-Brokx; C L Creasy; S K Verma; J Koster; X Wu; Y Yao; T Milde; P Sin-Chan; J Zuccaro; L Lau; S Pereira; P Castelo-Branco; M Hirst; M A Marra; S S Roberts; D Fults; L Massimi; Y J Cho; T Van Meter; W Grajkowska; B Lach; A E Kulozik; A von Deimling; O Witt; S W Scherer; X Fan; K M Muraszko; M Kool; S L Pomeroy; N Gupta; J Phillips; A Huang; U Tabori; C Hawkins; D Malkin; P N Kongkham; W A Weiss; N Jabado; J T Rutka; E Bouffet; J O Korbel; M Lupien; K D Aldape; G D Bader; R Eils; P Lichter; P B Dirks; S M Pfister; A Korshunov; M D Taylor
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

Review 9.  HOX genes and their role in the development of human cancers.

Authors:  Seema Bhatlekar; Jeremy Z Fields; Bruce M Boman
Journal:  J Mol Med (Berl)       Date:  2014-07-05       Impact factor: 4.599

10.  Quantitative Analysis of Differential Expression of HOX Genes in Multiple Cancers.

Authors:  Orit Adato; Yaron Orenstein; Juri Kopolovic; Tamar Juven-Gershon; Ron Unger
Journal:  Cancers (Basel)       Date:  2020-06-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.